Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10 participants
OBSERVATIONAL
2023-09-30
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Physical activity also has a protective effect in terms of tertiary prevention by reducing the risk of recurrence of certain cancers (breast, colon, prostate) by around 40 to 50% and by reducing overall mortality.
Adapted physical activity (APA) is offered at the Institut de Cancérologie de l'Ouest (ICO) in Angers, but there are obstacles particularly linked to the geographical distance of the establishment where this activity is offered.
The RAPASS project is a prospective study which will be proposed to patients followed at the ICO, living in rural areas and far from Angers. Its main objective is to describe the fatigue and quality of life of patients before, during and after a 13-session home-based APA programme. The data collected will also be used to describe changes in physical condition and level, compliance with the programme, continuation of physical activity beyond the duration of the programme, and satisfaction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EXPLORING the IMPACT of SUPERVISED PHYSICAL ACTIVITY INTERVENTION on CACHECTIC CANCER PATIENTS: a PRELIMINARY STUDY
NCT06651125
Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients
NCT05723471
Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients
NCT05056831
Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients
NCT05588700
Feasibility of a Novel, Theory Based Physical Activity Intervention Among Adult Cancer Survivors
NCT04498130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The programme is then carried out with the departmental sports for all committee 49.
The frequency of practice will ideally be one session per week at the patient's home, supervised by a coach from Departmental Committee for Sport for All in 49. A total of 13 sessions will be carried out.
The sessions will aim to develop all the components of physical fitness (endurance, strength, balance, flexibility, coordination, etc.).
The patient receives a walking logbook to record the number of daily steps taken, an exercise booklet to work independently and a pedometer.
In the presence of the coach, the patients perform different exercises and complete different questionnaires.
The programme is evaluated by the ICO EAPA 3 months after the 13th and final session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapted physical activity at home
The programme will take place over 6 months and will include :
1 consultation with the oncologist who will first assess the need for Adapted Physical Activity and then prescribe the APA with a certificate of no physical contraindication
1 consultation with the ICO's APA coach who will present the APA programme and assess the patient's physical capacity using the Short Physical Performance Battery (SPPB) test in order to adapt the programme to their needs.
13 home-based APA sessions (ideally one session per week) with the EAPA from Departmental Committee for Sport for All in 49
1 telephone call with the EAPA of the ICO to evaluate the programme 3 months after the last session.
Patients will also be asked to complete questionnaires at the first session (S1), halfway through the sessions (S6) and at the last session (S13).
These are FACIT-F 5Functional Assessment of Chronic Illness Therapy - Fatigue ; Ricci and L. Gagnon ; P-GIC (Patients' Global Impression of Change (PGIC) scale)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient living in a rural area
* Patient with a brain tumour and/or metastatic cancer
* Patient with a medical prescription for APA practice
* Patient with a certificate of no contraindication to physical activity
Exclusion Criteria
* Patient unable to undergo the trial procedures for social or psychological reasons
* Patient who does not understand French
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Cancerologie de l'Ouest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Loïc FAIVRE
Role: PRINCIPAL_INVESTIGATOR
Institut de Cancérologie de l'Ouest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut de Cancerologie de L'Ouest
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICO-2022-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.